Inozyme Pharma, Inc.
Inozyme Pharma, Inc. (INZY) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 75 transactions totaling $112.1M, demonstrating a bullish sentiment with $96.2M in net insider flow. The most recent transaction on Jul 1, 2025 involved a transaction of 1,571,741 shares valued at $6.3M.
INZY Insider Activity Summary
Who Is Buying INZY Stock?
No significant insider buying has been recorded for INZY in the recent period.
Who Is Selling INZY Stock?
No significant insider selling has been recorded for INZY in the recent period.
Is Inozyme Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INZY is bullish with an Insider Alignment Score of 93/100 and a net flow of $96.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INZY Frequently Asked Questions
Understanding INZY Insider Activity
Insider trading at Inozyme Pharma, Inc. (INZY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading INZY stock, having executed 75 transactions in the past 90 days. The most active insider is Robert Lorne Hopfner (Executive), who has made 12 transactions totaling $34.2M.
Related Tools
Track Inozyme Pharma, Inc. Insider Activity
Get notified when executives and directors at INZY file new Form 4 transactions